drugset / Trial / NCT00204256

Intravenous Iron in Patients With Anemia of Chronic Kidney Disease

NCT00204256

Phase 4 Unknown 50 enrolled University Hospital Muenster
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is the evaluation of the efficacy and safety of intravenous iron sucrose in anemic patients with chronic kidney disease not on renal replacement therapy.

Timeline

Start
2004-03
Primary completion
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron sucrose Unknown Intravenous